Skye Bioscience (SKYE) has released an update to notify the public and investors about a regulation fd disclosure.
On January 29, 2024, the Company issued a press release regarding a Private Placement and provided it as part of a Current Report. The information contained within, including an attached presentation, is for informational purposes and is not considered legally filed under the Securities Exchange Act nor is it to be included in the Company’s filings under the Securities Act.
For further insights into SKYE stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com